Literature DB >> 22868396

Lifestyle factors and antihypertensive treatment on the risks of ischemic and hemorrhagic stroke.

Yurong Zhang1, Jaakko Tuomilehto, Pekka Jousilahti, Yujie Wang, Riitta Antikainen, Gang Hu.   

Abstract

The joint relationship between healthy lifestyle and antihypertensive treatment with stroke risk is unclear. We prospectively investigated the individual and joint effects of healthy lifestyle factors and antihypertensive treatment on stroke risk among 36,686 Finnish participants aged 25 to 74 years and free of coronary heart disease and stroke at baseline. During a mean follow-up of 13.7 years, 1478 people developed stroke event (1167 ischemic and 311 hemorrhagic). The stroke risk was significantly decreased in people who adhered to ≥3 healthy lifestyle factors (never smoking, normal weight, moderate/high level of exercise, vegetable consumption≥3 times per week, and light/moderate alcohol drinking) compared with those who adhered to <3 healthy lifestyle factors. The stroke risk was significantly increased in unaware untreated, aware untreated, aware treated and controlled, and aware treated and uncontrolled hypertensive people than in normotensive people. The risks of stroke were decreased in people who adhered to ≥3 healthy lifestyle factors compared with those who adhered to <3 healthy lifestyle factors within different hypertensive status. Compared with hypertensive people who did not use antihypertensive drugs and adhered to ≥3 healthy lifestyle factors, the multivariable-adjusted hazard ratios in hypertensive people who used antihypertensive drugs and adhered to <3 healthy lifestyle factors were associated with 37% to 42% increased risks of total, ischemic, and hemorrhagic stroke in men and 121% to 131% increased risks of stroke in women. The present study demonstrates that a healthy lifestyle significantly decreases stroke risk in both men and women in different strata of hypertension status and antihypertensive drug treatments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868396     DOI: 10.1161/HYPERTENSIONAHA.112.193961

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

2.  Kidney function and the risk of cardiovascular disease in patients with type 2 diabetes.

Authors:  Yujie Wang; Peter T Katzmarzyk; Ronald Horswell; Wenhui Zhao; Jolene Johnson; Gang Hu
Journal:  Kidney Int       Date:  2013-10-09       Impact factor: 10.612

3.  Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.

Authors:  Maarit J Korhonen; Jaana Pentti; Juha Hartikainen; Jenni Ilomäki; Soko Setoguchi; Danny Liew; Mika Kivimäki; Jussi Vahtera
Journal:  J Am Heart Assoc       Date:  2020-02-05       Impact factor: 5.501

4.  Reduced Kidney Function Is Associated With Cardiometabolic Risk Factors, Prevalent and Predicted Risk of Cardiovascular Disease in Chinese Adults: Results From the REACTION Study.

Authors:  Jieli Lu; Yiming Mu; Qing Su; Lixin Shi; Chao Liu; Jiajun Zhao; Lulu Chen; Qiang Li; Tao Yang; Li Yan; Qin Wan; Shengli Wu; Yan Liu; Guixia Wang; Zuojie Luo; Xulei Tang; Gang Chen; Yanan Huo; Zhengnan Gao; Zhen Ye; Youmin Wang; Guijun Qin; Huacong Deng; Xuefeng Yu; Feixia Shen; Li Chen; Liebin Zhao; Jichao Sun; Wanwan Sun; Tiange Wang; Rui Du; Lin Lin; Meng Dai; Yu Xu; Min Xu; Yufang Bi; Shenghan Lai; Donghui Li; Weiqing Wang; Guang Ning
Journal:  J Am Heart Assoc       Date:  2016-07-22       Impact factor: 5.501

5.  Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial.

Authors:  Gilles R Dagenais; Hyejung Jung; Eva Lonn; Peter M Bogaty; Mahshid Dehghan; Claes Held; Alvaro Avezum; Petr Jansky; Matyàs Keltai; Lawrence A Leiter; Patricio Lopez-Jaramillo; William D Toff; Jackie Bosch; Salim Yusuf
Journal:  J Am Heart Assoc       Date:  2018-07-22       Impact factor: 5.501

6.  Hypothetical blood-pressure-lowering interventions and risk of stroke and dementia.

Authors:  Liliana Paloma Rojas-Saunero; Saima Hilal; Eleanor J Murray; Roger W Logan; Mohammad Arfan Ikram; Sonja A Swanson
Journal:  Eur J Epidemiol       Date:  2020-11-27       Impact factor: 8.082

7.  Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China.

Authors:  Qi Lu; Yanbo Zhang; Tingting Geng; Kun Yang; Kunquan Guo; Xinwen Min; Meian He; Huan Guo; Xiaomin Zhang; Handong Yang; Tangchun Wu; An Pan; Gang Liu
Journal:  JAMA Netw Open       Date:  2022-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.